Risk Factors for Rivaroxaban-Related Bleeding Events-Possible Role of Pharmacogenetics: Case Series

Risk Factors for Rivaroxaban-Related Bleeding Events-Possible Role of Pharmacogenetics: Case Series

Non-vitamin K antagonist oral anticoagulants' interindividual trough concentration variability affects efficacy and safety, especially in bleeding events. Rivaroxaban is metabolised via CYP3A4/5-, CYP2J2-, and CYP-independent mechanisms and is a substrate of two transporter proteins: ABCB1 (MDR...

Full description

Saved in:
Bibliographic Details
Main Authors: Livija Šimičević (Author), Ana Marija Slišković (Author), Majda Vrkić Kirhmajer (Author), Lana Ganoci (Author), Hrvoje Holik (Author), Jozefina Palić (Author), Jure Samardžić (Author), Tamara Božina (Author)
Format: Book
Published: MDPI AG, 2023-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items